ES2195002T3 - Antagonistas de los receptores de la endotelina. - Google Patents
Antagonistas de los receptores de la endotelina.Info
- Publication number
- ES2195002T3 ES2195002T3 ES96926841T ES96926841T ES2195002T3 ES 2195002 T3 ES2195002 T3 ES 2195002T3 ES 96926841 T ES96926841 T ES 96926841T ES 96926841 T ES96926841 T ES 96926841T ES 2195002 T3 ES2195002 T3 ES 2195002T3
- Authority
- ES
- Spain
- Prior art keywords
- antagonists
- endotheline
- receptors
- endotheline receptors
- tiazols
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBEN NUEVOS ISOXAZOLES, OXAZOLES, TIAZOLES, ISOTIAZOLES E IMIDAZOLES, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS Y SU USO COMO ANTAGONISTAS DEL RECEPTOR DE LA ENDOTELINA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US179495P | 1995-08-02 | 1995-08-02 | |
US1100996P | 1996-02-01 | 1996-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2195002T3 true ES2195002T3 (es) | 2003-12-01 |
Family
ID=26669476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96926841T Expired - Lifetime ES2195002T3 (es) | 1995-08-02 | 1996-08-02 | Antagonistas de los receptores de la endotelina. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0841926B1 (es) |
JP (1) | JPH11513022A (es) |
DE (1) | DE69626986T2 (es) |
ES (1) | ES2195002T3 (es) |
WO (1) | WO1997004774A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0885217A4 (en) * | 1996-02-01 | 1999-04-21 | Smithkline Beecham Corp | ENDOTHELIN RECEPTOR ANTAGONISTS |
ATE433106T1 (de) | 1998-12-23 | 2009-06-15 | Glaxo Group Ltd | Bestimmungsmethode fur liganden der nuklearen rezeptoren |
EP1454625A1 (en) * | 2003-03-06 | 2004-09-08 | Speedel Development AG | Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies |
MX2007002178A (es) | 2004-08-23 | 2007-04-02 | Wyeth Corp | Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares. |
MX2008015289A (es) * | 2006-05-29 | 2008-12-12 | Nicox Sa | Compuestos heterociclicos nitrados como antagonistas del receptor endotelina. |
CN104146998A (zh) * | 2014-08-05 | 2014-11-19 | 广东食品药品职业学院 | 5-羟基-7-甲氧基色原酮在制药中的新应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3700661A (en) * | 1968-11-22 | 1972-10-24 | Hoffmann La Roche | Total steroid synthesis employing substituted isoxazole derivatives |
CH641464A5 (de) * | 1979-11-22 | 1984-02-29 | Lonza Ag | Verfahren zur herstellung von 4-amino-6-hydroxy-3-phenyl-isoxazolo(5,4-b)pyridin-5-carbonitrilen. |
CA2018443A1 (en) * | 1989-06-14 | 1990-12-14 | Joseph A. Finkelstein | Imidazolyl-alkenoic acids |
JPH07509465A (ja) * | 1992-07-17 | 1995-10-19 | スミスクライン・ビーチャム・コーポレイション | エンドセリン受容体アンタゴニスト |
WO1994027597A1 (en) * | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
US5541213A (en) * | 1993-06-24 | 1996-07-30 | Eisai Co., Ltd. | Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility |
DE69526738T2 (de) * | 1994-09-02 | 2003-02-06 | Smithkline Beecham Corp., Philadelphia | Endothelin-rezeptor-antagonisten |
-
1996
- 1996-08-02 WO PCT/US1996/012584 patent/WO1997004774A1/en active IP Right Grant
- 1996-08-02 EP EP96926841A patent/EP0841926B1/en not_active Expired - Lifetime
- 1996-08-02 DE DE69626986T patent/DE69626986T2/de not_active Expired - Fee Related
- 1996-08-02 JP JP9507890A patent/JPH11513022A/ja not_active Ceased
- 1996-08-02 ES ES96926841T patent/ES2195002T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0841926A1 (en) | 1998-05-20 |
JPH11513022A (ja) | 1999-11-09 |
DE69626986T2 (de) | 2004-02-05 |
DE69626986D1 (de) | 2003-04-30 |
EP0841926A4 (en) | 1999-08-04 |
WO1997004774A1 (en) | 1997-02-13 |
EP0841926B1 (en) | 2003-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26808A1 (es) | Compuestos de succinimida heterocíclicos fusionados y análogos de los mismos, modulares de la función del receptor de hormona nuclear | |
BR9206237A (pt) | Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1. | |
ES2164054T3 (es) | Antagonistas de receptores de endotelina. | |
ES2172535T3 (es) | Antagonistas de los receptores de la endotelina. | |
MX9400071A (es) | Antagonistas del receptor de endotelina. | |
CR6478A (es) | Moduladores del receptor glucocorticoide | |
ES2091877T3 (es) | Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia. | |
BR0010215A (pt) | Derivados de indolina como antagonistas de progesterona | |
ES2191187T3 (es) | Compuestos heteroaromaticos biciclicos como inhibidores de la proteina tirosin-quinasa. | |
ECSP077236A (es) | Moduladores del receptor de progesterona que comprenden los derivados del pirrol-oxindol y los usos de los mismos | |
UY26482A1 (es) | Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales | |
EA199900045A1 (ru) | Производные спиропиперидина и их использование в качестве терапевтических агентов | |
MX9204786A (es) | Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene. | |
TR200002896T2 (tr) | Kalsilitik Bileşimler | |
AR002268A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. | |
AR008991A1 (es) | Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos | |
ES2190487T3 (es) | Nuevos agonistas y antagonistas del receptor de adenosina a1. | |
NO994850L (no) | Farmakologiske midler | |
MX9801890A (es) | Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen. | |
EE9800417A (et) | Dopamiini D4 retseptorite bensoksasinoonantagonistid | |
SV2002000005A (es) | Heterociclos 2-arilimino substituidos y composiciones que los contienen para usar como agentes que ligan el receptor de la progesterona ref. 5048p1-sv | |
ES2195002T3 (es) | Antagonistas de los receptores de la endotelina. | |
ES2171196T3 (es) | Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño. | |
ES2171697T3 (es) | Antagonistas del receptor de endotelina. | |
ES2166462T3 (es) | Antagonistas del receptor de la endotelina. |